The new facility uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
he company will focus on production of any pharmaceutical and biotechnological products
USFDA completes PAI of Lupin’s biotech facility in Pune
The inspection conducted by EDQM at its Visakhapatnam facility
HSGP is engaged closely with the USFDA and is committed to address the OAI observations through planned remediation measures
The Notes shall not be offered or sold in India
Eugia Steriles receives EIR from USFDA for new injectable facility
Fluoxetine Tabs 60 mg approval solidifies the company's position in the molecule by complementing the recent approval in April 2024 for Fluoxetine 10 mg and 20 mg tablets and Fluoxetine capsules
The sANDA was submitted as “Prior Approval Supplement” for addition of an alternate drug product manufacturing, labeling, packaging, and testing facility
Subscribe To Our Newsletter & Stay Updated
